Dillan Madhani

Dillan is an Associate in the Corporate and Life Sciences group in London. He specialises in advising companies and investors in the technology and life sciences sector on venture capital investments, M&A transactions and general corporate matters.

CV

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

2022 - 2022 Paralegal, Taylor Wessing

Karriere

Since 2024 Associate, Taylor Wessing

2022 - 2024 Trainee Solicitor, Taylor Wessing

2022 - 2022 Paralegal, Taylor Wessing

Ausbildung

2024 Admitted as a lawyer, England and Wales

2022 Master of Laws, BPP University (London)

2022 Legal Practice Course, BPP University (London)

News & Insights: Dillan Madhani

Zu den Insights

Klicken Sie hier für Details

M&A / Gesellschaftsrecht und Kapitalmarktrecht

Advising Rezolve AI on its US$230 million acquisition of Reward Loyalty UK Limited

12. Februar 2026

von mehreren Autoren

M&A / Gesellschaftsrecht und Kapitalmarktrecht

Advising Lingotto on its extended Series A funding into Optalysys to US$60 million

6. Februar 2026

von mehreren Autoren

Klicken Sie hier für Details

Expertise

Rechtsgebiete und Gruppen

Branchen

CV

Karriere

Ausbildung

News & Insights: Dillan Madhani

Advising Rezolve AI on its US$230 million acquisition of Reward Loyalty UK Limited

Dillan Madhani

Expertise

Rechtsgebiete und Gruppen

Branchen

CV

Karriere

Ausbildung

News & Insights: Dillan Madhani

Advising Rezolve AI on its US$230 million acquisition of Reward Loyalty UK Limited

Aktuelle News & Insights

Online-Coachings und Fernunterricht: BGH präzisiert Anwendung des FernUSG

Sparen um jeden Preis oder notwendige Maßnahmen?

PPWR-Handbuch

Aktuelle Entwicklungen in der Schweiz

Proposed Amendments to the EU Medical Device Regulation

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Impact of the new Biotech Act on Clinical Trials in the EU

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

"Krankenhausplanung geht Fusionskontrolle vor"

Advising on Sona's US$45 million Series B funding

Weitere Beraterinnen und Berater

Meet me at